Targeting aberrant learning may improve Parkinson's treatment

Northwestern Medicine scientists have discovered that targeting neuronal signaling controlling aberrant learning in the striatum may improve the efficacy of a first-line therapy for Parkinson’s disease and has the potential to reduce…

Continue Reading

News Source: medicalxpress.com